Relmada Therapeutics Inc (NAS:RLMD)
$ 3.69 0.16 (4.53%) Market Cap: 111.34 Mil Enterprise Value: 10.19 Mil PE Ratio: 0 PB Ratio: 1.30 GF Score: 31/100

Relmada Therapeutics Inc (RLMD) Transcripts

  • 1